YOLFTbeta
Bruker Corporation

Bruker Corporation

BRKR · NASDAQ · Healthcare / Medical Devices

61.59USD+1.26 (+2.09%)

Price History

Full chart

Market Stats

Previous Close60.33
Open60.36
Day Range59.13 – 61.94
52-Week Range29.96 – 65.26
Volume2.02M
Market Cap9.75B
P/E (TTM)0.00
Forward P/E13.83
EPS-0.75
Dividend Yield0.34%
Beta1.26
50-Day Avg58.38
200-Day Avg48.77

About

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Frank H. Laukien Ph.D.
  • Employees11.09K
  • Headquarters40 Manning Road, Billerica, MA, United States, 01821, USA
  • Websitehttps://www.bruker.com

Leadership

  • Dr. Frank H. Laukien Ph.D.Chairman, CEO & President · b. 1960
  • Mr. Gerald N. Herman CPAExecutive VP & CFO · b. 1958
  • Dr. Mark R. Munch Ph.D.Corporate Executive VP and President of Bruker Nano Group & Corporate · b. 1962
  • Mr. Juergen W. SregaPresident of Bruker Biosystems Group & Bruker Daltonics Division · b. 1955
  • Mr. Thomas M. BuresChief Accounting Officer · b. 1975
  • Mr. J. Brent Alldredge J.D.Senior VP, General Counsel, Secretary & Global Head of Compliance · b. 1975
  • Dr. Wolfgang Pusch Ph.D.President of Bruker Microbiology & Infection Diagnostics Group
  • Dr. Burkhard Prause Ph.D.President and CEO of Bruker Energy & Supercon Technologies, Inc. · b. 1967

Financials

Income Statement

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue42.21M64.69M76.60M92.69M116.37M260.68M284.42M297.57M435.83M547.58M1.11B1.11B1.30B1.65B1.79B1.84B1.81B1.62B1.61B1.77B1.90B2.07B1.99B2.42B2.53B2.96B3.37B3.44B
Growth (%)-+53.27%+18.41%+21.00%+25.54%+124.01%+9.11%+4.62%+46.46%+25.64%+102.18%+0.67%+17.08%+26.58%+8.46%+2.68%-1.66%-10.23%-0.77%+9.59%+7.34%+9.34%-4.11%+21.66%+4.67%+17.14%+13.56%+2.08%
Cost of Revenue-28.13M35.59M43.59M55.87M144.83M165.94M171.76M236.50M294.44M602.10M595.90M698.90M899.20M960.00M1.03B1.05B915.20M868.80M952.90M995.60M1.08B1.05B1.21B1.23B1.45B1.72B1.86B
Gross Profit42.21M36.56M41.02M49.10M60.50M115.84M118.48M125.81M199.33M253.14M505.00M518.60M606.00M752.50M831.40M805.20M763.30M708.60M742.50M813.00M900.00M995.30M939.80M1.21B1.31B1.51B1.65B1.58B
Gross Margin100.00%56.51%53.54%52.97%51.99%44.44%41.66%42.28%45.74%46.23%45.61%46.53%46.44%45.56%46.41%43.78%42.20%43.64%46.08%46.04%47.48%48.02%47.29%50.03%51.59%51.05%49.00%45.91%
Operating Expense42.37M33.38M40.28M45.83M54.75M125.53M119.59M115.17M168.67M203.17M396.80M381.90M450.30M596.90M675.40M657.00M657.90M562.90M565.30M598.30M637.60M694.40M691.50M796.30M873.00M1.08B1.40B1.34B
Operating Income-161.00K3.18M734.00K3.27M5.75M-9.68M-1.12M10.64M30.66M49.97M108.20M136.70M155.70M155.60M156.00M148.20M105.40M145.70M177.20M214.70M262.40M300.90M248.30M413.30M432.70M436.90M253.10M236.00M
Operating Margin-0.38%4.91%0.96%3.53%4.94%-3.71%-0.39%3.57%7.04%9.13%9.77%12.27%11.93%9.42%8.71%8.06%5.83%8.97%11.00%12.16%13.84%14.52%12.49%17.09%17.10%14.74%7.52%6.87%
EBITDA-161.00K6.66M4.88M10.29M17.47M697.00K8.68M19.25M49.87M63.07M134.80M166.30M155.70M205.70M211.70M239.10M215.60M228.60M262.10M299.50M340.10M372.00M320.60M497.10M518.70M675.50M438.60M302.60M
EBITDA Margin-0.38%10.30%6.37%11.11%15.01%0.27%3.05%6.47%11.44%11.52%12.18%14.92%11.93%12.45%11.82%13.00%11.92%14.08%16.27%16.96%17.94%17.95%16.13%20.56%20.50%22.79%13.03%8.81%
Net Income-888.00K1.25M2.25M3.64M-6.20M-17.55M-7.83M3.65M18.48M31.53M64.90M81.20M95.40M92.30M77.50M80.10M56.70M101.60M153.60M78.60M179.70M197.20M157.80M277.10M296.60M427.20M113.10M-8.60M
Net Income Margin-2.10%1.93%2.94%3.92%-5.33%-6.73%-2.75%1.23%4.24%5.76%5.86%7.29%7.31%5.59%4.33%4.35%3.13%6.26%9.53%4.45%9.48%9.51%7.94%11.46%11.72%14.41%3.36%-0.25%
R&D-15.14M20.03M18.47M20.73M38.03M43.22M41.36M49.96M58.47M133.80M126.40M141.40M177.20M195.30M190.50M174.20M145.70M149.00M162.70M173.40M187.70M198.00M220.80M235.90M294.80M376.50M395.20M
R&D as % of Total Revenue-23.40%26.15%19.92%17.82%14.59%15.20%13.90%11.46%10.68%12.09%11.34%10.84%10.73%10.90%10.36%9.63%8.97%9.25%9.21%9.15%9.06%9.96%9.13%9.32%9.94%11.18%11.50%
Interest Expense01.35M1.56M3.07M20.15M6.36M3.85M1.27M3.96M11.84M40.50M7.50M5.60M7.30M14.30M13.40M6.00M13.00M13.20M15.40M12.60M16.00M14.40M14.30M16.10M16.40M47.90M60.30M
Interest Expense % of Total Revenue0.00%2.09%2.04%3.31%17.31%2.44%1.35%0.43%0.91%2.16%3.66%0.67%0.43%0.44%0.80%0.73%0.33%0.80%0.82%0.87%0.66%0.77%0.72%0.59%0.64%0.55%1.42%1.75%

Balance Sheet

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets63.84M67.31M184.55M189.07M203.10M351.03M371.55M360.89M433.19M553.21M1.12B1.17B1.55B1.71B1.86B1.99B1.86B1.73B1.81B1.95B2.13B2.77B3.05B3.65B3.61B4.25B5.81B6.24B
Total Liabilities53.50M57.25M60.38M61.53M76.72M148.48M154.08M152.85M241.48M294.02M803.60M753.20M1.02B1.09B1.15B1.14B1.09B998.00M1.12B1.22B1.22B1.83B2.07B2.57B2.48B2.84B3.99B3.73B
Total Equity10.34M10.06M124.17M127.55M126.38M202.43M217.28M207.80M191.47M258.66M311.90M418.80M527.40M624.90M706.60M850.20M771.70M732.90M693.10M733.50M905.10M906.80M961.20M1.07B1.11B1.38B1.78B2.46B
Cash-2.44M21.73M8.38M32.16M62.64M32.55M53.16M52.15M72.88M166.20M207.10M230.40M246.00M310.60M438.70M319.50M267.10M342.40M325.00M322.40M678.30M681.80M1.07B645.50M488.30M183.40M298.80M
Total Debt-15.34M12.04M15.21M23.39M44.96M39.97M29.43M44.72M38.11M223.80M137.70M301.00M303.10M337.20M355.00M355.00M266.70M411.70M415.60M341.10M880.90M912.80M1.39B1.27B1.38B2.25B2.04B
Net Debt-12.90M-9.70M6.83M-8.77M-17.68M7.42M-23.73M-7.43M-34.77M57.60M-69.40M70.60M57.10M26.60M-83.70M35.50M-400.00K69.30M90.60M18.70M202.60M231.00M325.70M624.90M891.30M2.06B1.74B

Cash Flow

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.44M-202.00K-11.47M-11.39M-6.08M-889.00K42.19M37.69M28.21M106.90M149.80M156.10M87.70M133.10M145.00M114.30M229.20M130.80M154.40M239.70M213.40M333.20M282.40M262.00M350.10M251.30M134.10M
Investing Cash Flow-4.44M-85.53M-7.39M30.47M-10.44M-1.51M-10.45M12.30M-20.54M-47.70M-18.20M-299.00M-68.70M-93.20M-60.00M-201.90M-102.40M-21.80M-30.20M-123.40M-158.40M-192.70M-192.40M-251.60M-326.00M-1.76B-196.50M
Financing Cash Flow357.67K104.84M6.39M3.53M-8.14M6.77M-7.18M-64.39M9.10M-235.10M-84.10M168.30M3.30M34.40M26.50M6.70M-168.00M-27.20M-159.00M-112.40M300.00M-161.60M318.70M-415.20M-193.40M1.23B135.10M
Capital Expenditure4.24M5.58M17.59M15.92M5.49M7.26M3.21M7.62M16.08M47.40M16.30M31.90M54.40M72.80M50.30M33.80M34.20M37.10M43.70M49.20M73.00M98.20M92.00M119.00M106.90M115.30M120.20M
Free Cash Flow1.20M-5.78M-29.07M-27.31M-11.58M-8.15M38.98M30.07M12.13M59.50M133.50M124.20M33.30M60.30M94.70M80.50M195.00M93.70M110.70M190.50M140.40M235.00M190.40M143.00M243.20M136.00M13.90M
Dividends Paid----315.00K----23.40M-100.00K400.00K600.00K600.00K1.10M42.00M25.80M25.40M25.10M25.00M24.60M24.20M29.80M29.40M30.20M22.80M
FCF to OCF22.10%2862.87%253.33%239.74%190.24%917.10%92.39%79.78%43.00%55.66%89.12%79.56%37.97%45.30%65.31%70.43%85.08%71.64%71.70%79.47%65.79%70.53%67.42%54.58%69.47%54.12%10.37%
Dividend Paid to FCF-----2.72%----39.33%-0.08%1.20%1.00%0.63%1.37%21.54%27.53%22.94%13.18%17.81%10.47%12.71%20.84%12.09%22.21%164.03%

Earnings

Report DateNov 9, 2000Mar 1, 2001May 8, 2001Aug 7, 2001Nov 5, 2001Feb 21, 2002May 6, 2002Aug 7, 2002Nov 4, 2002Feb 20, 2003May 7, 2003Aug 6, 2003Nov 5, 2003Mar 2, 2004May 4, 2004Aug 3, 2004Nov 3, 2004Mar 2, 2005May 5, 2005Aug 3, 2005Nov 2, 2005Feb 22, 2006May 2, 2006Aug 1, 2006Nov 2, 2006Feb 22, 2007Apr 30, 2007Jul 31, 2007Oct 29, 2007Feb 28, 2008May 5, 2008Jul 31, 2008Oct 30, 2008Mar 3, 2009Apr 30, 2009Jul 29, 2009Oct 29, 2009Feb 25, 2010Apr 29, 2010Jul 28, 2010Oct 28, 2010Feb 23, 2011Apr 28, 2011Aug 3, 2011Oct 27, 2011Feb 22, 2012May 1, 2012Jul 31, 2012Nov 5, 2012Feb 19, 2013May 2, 2013Jul 31, 2013Nov 1, 2013Feb 18, 2014May 7, 2014Aug 6, 2014Nov 6, 2014Feb 19, 2015May 6, 2015Aug 5, 2015Nov 4, 2015Feb 10, 2016May 4, 2016Aug 2, 2016Nov 2, 2016Feb 13, 2017May 3, 2017Aug 3, 2017Nov 2, 2017Feb 8, 2018May 3, 2018Aug 2, 2018Nov 1, 2018Feb 11, 2019May 2, 2019Aug 1, 2019Oct 31, 2019Feb 18, 2020May 6, 2020Aug 3, 2020Nov 2, 2020Feb 16, 2021May 5, 2021Aug 2, 2021Nov 1, 2021Feb 11, 2022May 4, 2022Aug 3, 2022Nov 3, 2022Feb 9, 2023May 4, 2023Aug 3, 2023Nov 2, 2023Feb 13, 2024May 2, 2024Aug 6, 2024Nov 5, 2024Feb 13, 2025May 7, 2025Aug 4, 2025Nov 3, 2025Feb 12, 2026May 6, 2026Aug 4, 2026Nov 2, 2026
EPS Estimate0.010.010.010.020.020.010.020.020.020.030.030.020.010.010.01-0.030.010.01--0.010.020.020.020.040.080.040.050.050.110.060.090.120.120.050.070.070.200.080.120.120.270.150.200.230.290.120.120.160.240.140.140.220.280.090.190.150.290.100.170.130.270.150.200.200.360.190.200.260.490.230.250.300.540.240.300.380.590.220.050.310.560.330.380.440.580.420.450.560.720.550.490.630.660.460.510.600.740.440.420.320.650.230.380.42
EPS Actual0.010.040.020.020.020.020.020.020.030.020.020.010.010.010.01-0.04-0.010.010.000.000.010.020.020.020.040.090.040.050.060.170.030.130.110.180.050.080.100.270.100.150.190.270.110.170.160.300.110.120.280.280.080.180.200.310.110.210.140.300.140.190.190.380.210.200.320.460.190.230.290.510.240.250.370.540.280.330.430.530.140.210.420.580.440.440.630.590.490.450.660.740.640.500.740.700.530.520.600.760.470.320.450.590.310.49-
Surprise0.00%300.00%100.00%0.00%0.00%100.00%0.00%0.00%50.00%-33.33%-33.33%-50.00%0.00%0.00%0.00%-33.33%-200.00%0.00%--0.00%0.00%0.00%0.00%0.00%12.50%0.00%0.00%20.00%54.55%-50.00%44.44%-8.33%50.00%0.00%14.29%42.86%35.00%25.00%25.00%58.33%0.00%-26.67%-15.00%-30.43%3.45%-8.33%0.00%75.00%16.67%-42.86%28.57%-9.09%10.71%22.22%10.53%-6.67%3.45%40.00%11.76%46.15%40.74%40.00%0.00%60.00%27.78%0.00%15.00%11.54%4.08%4.35%0.00%23.33%0.00%16.67%10.00%13.16%-10.17%-36.36%320.00%35.48%3.57%33.33%15.79%43.18%1.72%16.67%0.00%17.86%2.78%16.36%2.04%17.46%6.06%15.22%1.96%0.00%2.70%6.82%-23.81%40.63%-9.23%34.78%28.95%-
Timing-----------After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hoursAfter-hours-After-hoursPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap9.75B
Enterprise Value10.69B
Trailing P/E0.00
Forward P/E13.83
PEG Ratio1.52
Price / Sales2.79
Price / Book3.82
EPS-0.75
Book Value15.63
Revenue (TTM)3.50B
Gross Profit (TTM)1.70B
EBITDA541.10M
Profit Margin-2.04%
Operating Margin9.88%
Return on Equity-3.00%
Return on Assets3.14%
Shares Outstanding152.36M
Shares Float103.69M
Beta1.26
Dividend Yield0.34%
Dividend Rate0.20
Payout Ratio10.87%

Analyst Ratings

Buy
Based on 14 analystsTarget 60.00
  • Strong Buy
    5
  • Buy
    2
  • Hold
    7

Ownership Breakdown

Institutions
95.82%
Insiders
26.97%
Retail / Other
0.00%

Top Institutional Holders

  • Orbis Allan Gray Ltd
    17.94M11.77%
  • FMR Inc
    16.10M10.57%
  • BlackRock Inc
    11.18M7.34%
  • Pallas Capital Advisors LLC
    9.48M6.22%
  • Vanguard Portfolio Management, LLC
    4.86M3.19%
  • Vanguard Capital Management, LLC
    4.82M3.16%
  • State Street Corp
    3.91M2.57%
  • OZ Management LLC
    3.27M2.15%
  • Franklin Templeton Inc
    2.92M1.92%
  • Sachem Head Capital Management LP
    2.92M1.91%
  • Edmond de Rothschild Holding S.A.
    2.82M1.85%
  • Dimensional Fund Advisors, Inc.
    2.61M1.71%
  • London Company of Virginia
    2.58M1.70%
  • T. Rowe Price Associates, Inc.
    2.47M1.62%

Top Fund Holders

  • iShares Core S&P Mid-Cap ETF
    3.89M2.55%
  • Orbis Global Equity Investor
    3.82M2.51%
  • Vanguard MStar Total Stk Mkt Idx Invest
    3.39M2.22%
  • Strategic Advisers Fidelity US TtlStk
    2.82M1.85%
  • Vanguard Small Cap Index
    2.45M1.61%
  • Fidelity Series Large Cap Stock
    2.36M1.55%

Dividends

20263×
0.05Sep 21, 20260.05Jun 22, 20260.05Mar 23, 2026
20254×
0.05Dec 8, 20250.05Sep 23, 20250.05Jun 16, 20250.05Mar 17, 2025
20244×
0.05Dec 2, 20240.05Aug 30, 20240.05Jun 3, 20240.05Feb 29, 2024
20234×
0.05Nov 30, 20230.05Aug 31, 20230.05May 31, 20230.05Feb 28, 2023
20224×
0.05Nov 30, 20220.05Aug 31, 20220.05May 31, 20220.05Feb 28, 2022
20214×
0.04Nov 30, 20210.04Aug 31, 20210.04May 28, 20210.04Mar 4, 2021
20201×
0.04Nov 30, 2020